Trending:
-
18 February 2019
US regulator seeks additional details on $4.2bn Boston Scientific-BTG deal
The US Federal Trade Commission (FTC) has requested for additional information and documentary material from Boston Scientific and BTG on their proposed $4.2bn acquisition deal.
-
14 February 2019
J&J to acquire surgical robotics firm Auris Health for $3.4bn
Johnson & Johnson (J&J), through its subsidiary Ethicon, has signed a definitive agreement to buy surgical robotics maker Auris Health for a cash consideration of around $3.4bn
-
13 February 2019
Edwards Lifesciences to buy CASMED for $100m
Edwards Lifesciences has signed a definitive agreement to acquire medical technology company CAS Medical Systems (CASMED) in an all-cash transaction valued at around $100m, or $2.45 per share.
-
7 February 2019
Current Health gets FDA clearance for remote monitoring device
Scottish medical device maker Current Health has secured the US Food and Drug Administration (FDA) clearance for its artificial intelligence (AI) enabled, wearable, remote patient monitoring device.
-
6 February 2019
Teva expected to sell Israeli medical equipment plant for $45m
Israeli pharmaceutical company Teva is expected to announce the sale of its Migada medical equipment plant to private equity investor FIMI Opportunity Funds for $45m.
-
4 February 2019
FDA issues warning on accuracy of Roche’s warfarin test strips
The US Food and Drug Administration (FDA) has issued a warning that certain Roche Diagnostics test strips used with a CoaguChek test meter device to monitor warfarin levels may deliver...
-
1 February 2019
Sirakoss’ Osteo bone graft substitute obtains CE-Mark
UK-based Sirakoss has received CE-Mark clearance for the use of its new nanosynthetic bone graft substitute Osteo, which improves healing in patients who require bone fractures repair.
-
1 February 2019
Deals this week: Accuray, Thermo Fisher, Circassia
Accuray has formed a joint venture (JV) with China Isotope and Radiation Corporation (CIRC) for the manufacturing and commercialisation of radiation oncology systems in China.
-
1 February 2019
M&As this week: Medtronic, BioTelemetry, Labcyte
Medtronic has agreed to acquire EPIX Therapeutics for an undisclosed sum.
-
31 January 2019
C2N Diagnostics’ Alzheimer’s test gets FDA breakthrough status
C2N Diagnostics has received breakthrough device designation from the US Food and Drug Administration (FDA) for its brain amyloidosis blood test to screen Alzheimer’s disease risk.